SHARE:

Browse Programs

Browse the program schedule for the 2018 Breakthroughs in Neurology Conference. 

*Programs current as of September 5, 2017. Information subject to change.

View the 2018 Breakthroughs in Neurology brochure.

Friday, January 12

8:00 a.m.-10:00 a.m.

10:15 a.m.-11:45 a.m.

11:45 a.m.-12:45 p.m.

1:15 p.m.-3:15 p.m.

3:30 p.m.-5:00 p.m.

Saturday, January 13

8:00 a.m.-10:00 a.m.

10:15 a.m.-11:45 a.m.

11:45 a.m.-12:45 p.m. 

1:15 p.m.-3:15 p.m.

3:30 p.m.-5:00 p.m.

5:00 p.m.-6:00 p.m.

Sunday, January 14

8:00 a.m.-5:00 p.m.

Monday, January 15

8:00 a.m.-12:00 p.m.

Program Descriptions

Multiple Sclerosis in Advanced Age: From Diagnosis to End of Life 
Day: Friday
Date: January 12, 2018 
Time: 8:00 a.m.-10:00 a.m.
CME: 2 hours
Program Director: Gabriele C. De Luca, MD, PhD, Oxford, United Kingdom
Program Description: Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system that typically first manifests in young adults. With an ageing population and increasing prevalence of MS, there is heightened awareness that MS can present later in life and its clinical outcomes can be adversely impacted by age-related comorbidities. These factors along with the inherent complexity and heterogeneity of the disease pose unique challenges to the clinician in the diagnosis, treatment, and end of life care of MS in advanced age. This multidisciplinary program covers the breadth of these topics to provide clinicians with the foundation necessary to provide the highest standard of care to this increasingly common, but relatively neglected, MS patient group.
Learning Objectives: Upon completion, delegates should be able to recognize common diagnostic pitfalls and treatment considerations of MS in advanced age, understand the range of age-related co-morbidities in people with MS and their impact on clinical outcome, appreciate the pathological features of MS in the elderly, and demonstrate awareness of the complexities of palliative care in MS.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-Neurologist, Residents, Nurses, Neurohospitalist, Advanced Practice Provider
Core Competencies: Patient Care, Medical Knowledge, Practice-based Learning and Improvement

Program Timeline
8:00 a.m.-8:05 a.m. 
Introduction
Gabriele De Luca, MD, PhD, Oxford, United Kingdom
 
8:05 a.m.-8:30 a.m.
Diagnostic Challenges and Treatment Considerations in Late Onset MS
Mark Keegan, MD, Rochester, MN
 
8:30 a.m.-8:55 a.m.
Age-related Co-morbidities in MS
TBD 

8:55 a.m.-9:20 a.m.
MS Pathology in Old Age
Gabriele De Luca, MD, PhD, Oxford, United Kingdom

9:20 a.m.-9:45 a.m.
Palliative Care in MS
Maisha Robinson, MD, MS, Jacksonville, FL

9:45 a.m.-10:00 a.m.
Questions and Answers
Faculty


Zika Virus: Neurological Complications and Updates
Day: Friday
Date: January 12, 2018
Time: 8:00 a.m.-10:00 a.m.
CME: 2 hours
Program Director: Marie Francisca Grill, MD, Phoenix, AZ
Program Description: Zika virus is an emerging flavivirus transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Zika has quickly established a reputation for neurotropism with associated cases of acute flaccid paralysis thought to be secondary to Guillain-Barré syndrome, and of microcephaly due to congenital Zika infection. Case reports and case series will be reviewed to highlight the spectrum of Zika-related neurological complications. Epidemiological and scientific updates will be provided.
Learning Objectives: Participants should become familiar with the epidemiology, transmission, clinical presentations, and neurological syndromes associated with Zika virus infection, as well as scientific updates.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-Neurologist, Residents, Neurohospitalist, Advanced Practice Provider
Core Competencies: Patient Care, Medical Knowledge

Program Timeline
TBD


Getting Paid in the Future: Accountable Care Organizations (ACOs), Alternate Payment Models, Value-based Purchasing, MIPS…and Then Some
Day: Friday
Date: January 12, 2018
Time: 10:15 a.m.-11:45 a.m.
CME: 1.5 hours
Program Directors: Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA, and Lyell K. Jones, MD, FAAN, Rochester, MN
Program Description: As providers move to a reimbursement model that focus on value-based care, current programs continue to evolve while new models develop. Furthermore, the impact of these programs on providers' time, effort, and personal finances may be opaque. This course will provide a broad overview of current and future value-based care approaches for practicing neurologists in academic and private practice settings. The course will discuss and clarify key considerations, including utilization of quality metrics, cost assessment, and risk adjustment. The course will also shed light into potential impact on neurologists and assist them in their ability to succeed and/or lead within these models. Neurologists will also learn about value-based care options that can be performed independently, such as utilization of qualified clinical data registries like the Axon Registry®.
Learning Objective: Participants should be able to understand importance of moving toward a value-based reimbursement model; understand major differences amongst the various value-based care models and how they operate; understand considerations necessary prior to joining a value-based model, including strategic skill sets needed to be successful in each model, and a better appreciation of value-based care options outside these models like the Axon Registry; and understand implications of legislation on regulations impacting neurologists such as MACRA.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Residents, Neurohospitalist
Core Competencies: Patient Care, Practice-based Learning and Improvement, Systems-based Practice

Program Timeline
10:15 a.m.-10:55 a.m.  
Deciphering Payment Models: Making Sense of It All
Brad C. Klein, MD, MBA, FAAN, Willow Grove, PA

10:55 a.m.-11:35 a.m.  
MIPS and the Axon Registry: What It Means to You 
Lyell K. Jones, MD, FAAN, Rochester, MN

11:35 a.m.-11:45 a.m. 
Questions and Answers
Faculty


Is There a Neurologist on This Flight?
Day: Friday
Date: January 12, 2018
Time: 11:45 a.m.-12:45 p.m.
CME: 1 hour
Program Director: Joseph I. Sirven, MD, FAAN, Phoenix, AZ
Program Description: Flying is one of the most common transportation means in the US. However with ever more crowded planes, neurologists and all health professionals are often tasked with coming to the aid of fellow passengers in air emergencies. What are the rules of such encounters? Must you volunteer, what exactly is available on a plane that can help a patient in need of care? Through a highly interactive session, answers are provided so that the next time a flight attendant asks, "Is there a neurologist on this flight?" you are prepared.
Learning Objectives: Participants should become familiar with the process and equipment that airlines follow for in-flight emergencies and understand the laws that guide these encounters.
Recommended Audience: Practitioners, Trainees, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-neurologist, Residents, Nurses, Advanced Practice Provider
Core Competencies: Patient Care, Interpersonal and Communication Skills, Medical Knowledge, Systems-based Practice

Program Timeline
11:45 a.m.-12:45 p.m.
Is There a Neurologist on This Flight?
Joseph I. Sirven, MD, FAAN, Phoenix, AZ


Neuroscience in the Clinic: Treatment of Progressive Multiple Sclerosis
Day: Friday
Date: January 12, 2018
Time:  1:15 p.m.-3:15 p.m.
CME: 2 hours
Program Director: Eric Klawiter, MD, Boston, MA
Program Description: Advances in the understanding of multiple sclerosis have opened up potential therapeutic targets. While relapsing-remitting multiple sclerosis has many treatment options, many of these therapies lack efficacy in progressive MS. Faculty will discuss how to assess and follow progressive MS with a focus on the latest clinical trial results and therapeutic candidates.
Learning Objectives: Participants should become familiar with the pathogenesis of progressive multiple sclerosis and how to assess progressive multiple sclerosis. They should be equipped to improve their management of patients with progressive multiple sclerosis.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-Neurologist, Residents, Nurses, Neurohospitalist, Advance Practice Provider
Core Competencies: Patient Care, Medical Knowledge

Program Timeline
1:15 p.m.-1:20 p.m.  
Introduction
Eric Klawiter, MD, Boston, MA
 
1:20 p.m.-1:35 p.m.  
Case Studies on Progressive MS
Eric Klawiter, MD, Boston, MA

1:35 p.m.-2:00 p.m.  
Neuropathology of Progressive MS
Gabriele C. De Luca, MD, PhD, Oxford, United Kingdom

2:00 p.m.-2:25 p.m.  
MRI and Other Biomarkers for Progressive MS
Eric Klawiter, MD, Boston, MA

2:25 p.m.-2:30 p.m.  
Break

2:30 p.m.-3:00 p.m.  
Evidence-based Treatment of Progressive MS
Ellen M. Mowry, MD, FAAN, Baltimore, MD

3:00 p.m.-3:15 p.m.  
Discussion
Faculty


Neuroscience in the Clinic: Emerging Neurological Infections 
Day: Friday
Date: January 12, 2018
Time: 1:15 p.m.-3:15 p.m.
CME: 2 hours
Program Director: Kiran Thakur, MD, New York, NY
Program Description: The list of emerging and reemerging pathogens that cause neurologic syndromes is growing. Not only have advances in diagnostic methods led to the identification of novel pathogens but also several recognized neurotropic pathogens have expanded their geographic distribution. New challenges have emerged in an increasingly immunocompromised population due to advances in the treatment of rheumatologic disease, neurological disorders including multiple sclerosis, and transplant medicine. In this program, we will provide a case-based scientific discussion highlighting updates on the most recent emerging neurological infections including Zika virus, Enterovirus D68, and Powassan virus. We will discuss factors involved in the emergence of these infections, and the current state of knowledge in the diagnosis, clinical presentation, treatment and outcome of patients affected by these emerging neurotropic infections. We will then highlight knowledge gained from neurological manifestations of two major infectious disease outbreaks, the HIV pandemic and Ebola virus outbreak. We will discuss concepts associated with entry of infection in the brain/spinal cord, the role of immune response, and the role that the nervous system plays as a reservoir for infection.
Learning Objectives:  Participants should learn broad concepts relevant to the neurotropism of infectious diseases, and also specific clinical and scientific updates on emerging neurological infections of public health significance.
Recommended Audience: TB
Core Competencies: TBD

Program Timeline
1:15 p.m.-1:20 p.m.
Introduction
Kiran Thakur, MD, New York, NY

1:20 p.m.-2:10 p.m.
Emerging Neurological Infections: Zika, EV 68, Powassan 
Daniel Pastula, MD, MHS, Aurora, CO

2:10 p.m.-3:00 p.m.
Neurological Manifestations in HIV and Ebola: What Can We Learn from Historical Outbreak 
Avindra Nath, MD, MBBS, FAAN, Bethesda, MD

3:00 p.m.-3:15 p.m.
Questions and Answers
Faculty


Hot Topics Session
Day: Friday
Date: January 12, 2018
Time: 3:30 p.m.-5:00 p.m.
CME: 1.5 hours
Moderator: Natalia S. Rost, MD, MPH, FAAN, Boston, MA
Program Description: This session features translational research related to clinical issues of importance. Four outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results.
Recommended Audience: General Neurologist, Specialist Neurologist, Non-neurologist
Core Competencies: Medical Knowledge

Program Timeline
3:30 p.m.-3:50 p.m.  
Dopamine Oxidation Mediates a Human-specific Cascade of Mitochondrial and Lysosomal Dysfunction in Parkinson's Disease 
Dimitri Krainc, MD, PhD, Chicago, IL

3:50 p.m.-4:10 p.m.  
Antisense Oligonucleotide Treatment (ASO) and SMA: Results of Clinical Trials
Claudia A. Chiriboga, MD, New York, NY

4:10 p.m.-4:30 p.m.  
Population-based Comprehensive Epilepsy Care in Ontario, Canada: A Model Network
O. Carter Snead, III, MD, FAAN, Toronto, ON, Canada

4:30 p.m.-4:50 p.m.  
Ocrelizumab for Relapsing and Progressive Multiple Sclerosis
Mark Keegan, MD, Rochester, MN


Epilepsy: Optimizing Care in Challenging Clinical Scenarios
Day: Saturday
Date: January 13, 2018
Time: 8:00 a.m.-10:00 a.m.
CME: 2 hours
Program Director: Katherine H. Noe, MD, PhD, FAAN, Phoenix, AZ
Program Description: Epilepsy care can be highly nuanced, particularly when seizures are symptomatic of an underlying disorder. This program will focus on the unique considerations for epilepsy diagnosis and management in specific populations including persons with brain injury, autoimmune disorders, and in pregnancy. Speakers will provide case-based discussions illustrating current best practices and highlighting solutions to common challenges encountered in inpatient and outpatient neurologic practice.
Learning Objectives: Participants should have acquired clinical knowledge to optimize the work-up and management of seizures seen in association with traumatic brain injury, autoimmune epilepsy, and in women of childbearing potential.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Specialist Neurologist, Residents, Nurses, Advanced Practice Provider
Core Competencies: Patient Care, Medical Knowledge

Program Timeline
8:00 a.m.-8:35 a.m.  
Post-Traumatic Epilepsy
Jose E. Cavazos, MD, PhD, FAAN, San Antonio, TX

8:35 a.m.-9:10 a.m.  
Autoimmune Epilepsy
Lily Wong-Kisiel, MD, Rochester, MN

9:10 a.m.-9:45 a.m. 
Pregnancy, Breastfeeding, and Contraception in Women with Epilepsy
Katherine H. Noe, MD, PhD, FAAN, Phoenix, AZ

9:45 a.m.-10:00 a.m.  
Questions and Answers 
Katherine H. Noe, MD, PhD, FAAN, Phoeniz, AZ, and Jose E. Cavazos, MD, PhD, FAAN, San Antonio, TX


Neuromuscular Treatment Updates: Myasthenia Gravis and Motor Neuron Disease 
Day: Saturday
Date: January 13, 2018
Time: 8:00 a.m.-10:00 a.m.
CME: 2 hours
Program Director: Madhu Soni, MD, Chicago, IL
Program Description: Recent advances have been made in therapeutic options for treating neuromuscular conditions. Through presentation of recently published clinical trial results, this program will focus on treatment of myasthenia gravis, spinal muscular atrophy, and amyotrophic lateral sclerosis.
Learning Objectives: Based on evidence from clinical trials, participants should become familiar with expanded treatment options for myasthenia gravis, spinal muscular atrophy and amyotrophic lateral sclerosis.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-neurologist, Residents, Nurses, Advanced Practice Provider
Core Competencies: Patient Care, Medical Knowledge, Practice-based Learning and Improvement

Program Timeline
8:00 a.m.-8:05 a.m.  
Neuromuscular Treatment Updates: Myasthenia Gravis and Motor Neuron Disease 
Madhu Soni, MD, Chicago, IL

8:05 a.m.-8:50 a.m.  
Treatment Updates on Myasthenia Gravis
Kerry H. Levin, MD, FAAN, Cleveland, OH

8:50 a.m.-9:00 a.m.  
Myasthenia Gravis: Questions and Answers
Kerry H. Levin, MD, FAAN, Cleveland, OH

9:00 a.m.-9:45 a.m.  
Treatment Updates on Spinal Muscular Atrophy and Amyotrophic Lateral Sclerosis
Petra Kaufmann, MD, FAAN
 
9:45 a.m.-10:00 a.m.  
SMA and ALS: Questions and Answers
Petra Kaufmann, MD, FAAN, Bethesda, MD


Building Care Teams (Doctors, Advanced Practice Providers, Pharmacists, Emotional Support, and Patient Navigators)
Day:
Saturday
Date: January 13, 2018
Time: 10:15 a.m.-11:45 a.m.
CME: 1.5 hours
Program Director: Allison L. Weathers, MD, FAAN, Beachwood, OH, and David A. Evans, MBA, Dallas, TX
Program Description: Neurologists are facing a number of disruptions in how they have traditionally practiced, including a transition to value-based payment models, physician burnout, and an increasing demand for patient access, superimposed with a projected provider shortage. Regardless of practice setting, the development of a robust and data-driven care team in which each member has a clearly defined role and is empowered to practice to the top of their license is necessary to ensure continued success in this new practice environment. Through the use of real-world case scenarios, the presenters will review the key components and considerations for building and maintaining a successful care team.
Learning Objectives: Participants should be able to identify the benefits, requirements, and challenges of implementing a care team as well as strategies for continued optimal use, including neurology-specific use cases.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Non-neurologist, Residents, Nurses, Neurohospitalist, Advances Practice Provider, Other
Core Competencies: Patient Care, Practice-based Learning and Improvement, Systems-based Practice

Program Timeline
10:15 a.m.-11:30 a.m.  
Building Care Teams (Doctors, Advanced Practice Providers, Pharmacists, Emotional Support, and Patient Navigators)
Allison L. Weathers, MD, FAAN, Beachwood, OH, and David A. Evans, MBA, Dallas, TX

11:30 a.m.-11:45 a.m.
Questions and Answers
Faculty  


Presentation Stage: “Ask Me Anything” Panel Discussion: Cerebrovascular Disease and Multiple Sclerosis
Day:
Saturday
Date: January 13, 2018
Time: 11:45 a.m.-12:45 p.m.
CME: 1 hour
Panel Members:
Eric Klawiter, MD, Boston, MA
John Corboy, MD, FAAN, Aurora, CO
Natalia S. Rost, MD, MPH, FAAN, Boston, MA
Paul M. George, MD, PhD, MSE, Stanford, CA
Randolph S. Marshall, MD, FAAN, New York, NY
Robert D. Brown, Jr., MD, FAAN, Rochester, MN
Gabriele C. De Luca, MD, PhD, Oxford, United Kingdom
Neeta Garg, MD, Worcester, MA
Larry B. Goldstein, MD, FAAN, FAHA, Lexington, KY
Bruce I. Ovbiagele, MD, MSc, FAAN, Charleston, SC
Andrew Mebane Southerland, MD, Charlottesville, VA

Program Description: TBD
Recommended Audience: TBD
Core Competencies: TBD

Program Timeline
11:45 a.m.-12:45 p.m.
“Ask Me Anything” Panel Discussion: Cerebrovascular Disease and Multiple Sclerosis
Faculty 


Neuroscience in the Clinic: Epilepsy
Day:
Saturday
Date: January 13, 2018 
Time: 1:15 p.m.-3:15 p.m.
CME: 2 hours
Program Director: Amy R. Brooks-Kayal, MD, FAAN, Aurora, CO
Program Description: Advances in our understanding of the mechanisms underlying the development of epilepsy and in new technologies for real-time seizure detection and intervention have the potential to transform the care of people with epilepsy in the next few years. Our speakers will discuss new therapies for seizures in preclinical and clinical development that are highly precise, temporally, spatially, and mechanistically. In addition, we will discuss therapies on the horizon for epilepsy that have the potential to be truly disease modifying, reducing the risk of developing epilepsy in those at risk and/or reducing progression or severity of established epilepsy.
Learning Objectives: Participants should become familiar with new therapies for epilepsy in preclinical and clinical development.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Residents
Core Competencies: Patient Care, Medical Knowledge

Program Timeline
1:15 p.m.-1:45 p.m.  
Getting from Mechanisms to Therapies: New Treatments on the Horizon for Epilepsy
Amy R. Brooks-Kayal, MD, FAAN, Aurora, CO

1:45 p.m.-1:55 p.m.  
Questions and Answers
Amy R. Brooks-Kayal, MD, FAAN, Aurora, CO

1:55 p.m.-2:25 p.m.
Coming Soon to a Patient Near You: New Drugs for Epilepsy in the Clinical Research Pipeline 
Joseph I. Sirven, MD, FAAN, Phoenix, AZ

2:25 p.m.-2:35 p.m. 

Questions and Answers 
Joseph I. Sirven, MD, FAAN, Phoenix, AZ

2:35 p.m.-3:05 p.m. 
Coming Soon to a Patient Near You: New Devices for Epilepsy in the Clinical Research Pipeline
Jose E. Cavazos, MD, PhD, FAAN, San Antonio, TX

3:05 p.m.-3:15 p.m.
Questions and Answers
Jose E. Cavazos, MD, PhD, FAAN, San Antonio, TX


Neuroscience in the Clinic: Neuromuscular 
Day: Saturday
Date: January 13, 2018 
Time: 1:15 p.m.-3:15 p.m.
Program Director: Michael E. Shy, MD, Iowa City, IA
Program Description: The program will begin with presenting a case of patients with a genetic nueromuscular disease with emphasis on how the patients were evaluated. A Certified Genetic Counselor will review how the family was involved in the work-up, including approaches taken to establish a diagnosis in the most cost effective way to the patient. Faculty will go over the use and interpretation of Next Generation Sequencing to explain its use in making the diagnosis and review the biology of the causal gene and protein.
Learning Objectives: Participants should become familiar with the differential diagnosis and work-up for both common and rare forms of neuromuscular disease presenting in childhood and adulthood, including approaches in the efficient use of genetic testing and get an update on linking genetic causes to cell biology and therapeutic approaches to genetic neuromuscular disease.
Recommended Audience: Practitioners, Trainee, General Neurologist, Fellows, Academicians, Specialist Neurologist, Residents, 
Core Competencies: Patient Care, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement

Program Timeline

TBD


Contemporary Clinical Issues Session 
Day: Saturday
Date: January 13, 2018
Time: 3:30 p.m.-5:00 p.m.
CME: 1.5 hours
Moderator: Amy R. Brooks-Kayal, MD, FAAN, Aurora, CO
Program Description: This session highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments.
Recommended Audience: General Neurologist, Specialist Neurologist, Non-Neurologist
Core Competencies: Medical Knowledge

Program Timeline
3:30 p.m.-4:00 p.m.  
Nusinersen in Infants Diagnosed with Spinal Muscular Atrophy (SMA): Study Design and Initial Interim  Efficacy and Safety Findings from the Phase 3 International ENDEAR Study
Nancy L. Kuntz, MD, Chicago, IL

4:00 p.m.-4:30 p.m.  
Resumption of Oral Anticoagulation After Intracerebral Hemorrhage Is Associated with Decreased Mortality and Favorable Functional Outcome
Alessandro Biffi, MD, Boston, MA

4:30 p.m.-5:00 p.m.  
High Drug Prices: The Elephant in the Clinic 
Dennis N. Bourdette, MD, FAAN, Portland, OR 


ABPN Maintenance of Certification Informational Session 
Day: Saturday
Date: January 13, 2018
Time: 5:00 p.m.-6:00 p.m.
Speakers: Laurie Gutmann, MD, FAAN, Iowa City, IA, Representative, American Board of Psychiatry and Neurology and A. Gordon Smith, MD, FAAN, Salt Lake City, UT, Chair, AAN Education Committee
Program Description: The American Board of Psychiatry and Neurology (ABPN) will inform attendees about the Maintenance of Certification (MOC) requirements as mandated by the American Board of Medical Specialties (ABMS). The AAN Institute will provide information about MOC resources.

*The Maintenance of Certification Program is a program of the American Board of Psychiatry and Neurology as mandated by the American Board of Medical Specialties. For information about your individual MOC requirements, please contact the ABPN at (847) 229-6500 or ABPN.com.


Neurology MOC Prep Course
Days: Saturday and Sunday
Dates: January 14, 2018, and January 15, 2018 
Time: January 14, 2018, 8:00 a.m.-5:00 p.m. and January 15, 2018, 8:00 a.m.-12:00 p.m.
Self-assessment CME: 11.25 hours
Program Director: Ralph F. Józefowicz, MD, FAAN, Rochester, NY
Program Description: This course is designed to prepare neurologists for the ABPN MOC examination. The course will feature 10 lectures covering the major topics stressed on the ABPN MOC examination: Vascular diseases, Demyelinating Disorders, Developmental and Congenital Disorders, Epilepsy, Brain and Spine Trauma, Headache and Pain, Neuromuscular Disorders, Movement Disorders, Sleep Disorders, and Infectious Diseases. The presentations will be given by the authors of the AAN MOC On-Line Prep Course product. The program will incorporate pre-test questions for each presentation to assist attendees in identifying areas that require focused study. The course will conclude with information concerning the new ABPN MOC requirements, including enrollment in the Continuous Maintenance of Certification (C-MOC) program. Presentations and syllabus materials will be provided and will include resources for ongoing study and review.
Learning Objectives: Participants should be able to identify areas of neurology that require more focused study and review in preparation for the MOC examination; self-assess knowledge after completion of the educational program to further focus study and review; and demonstrate improved competency and performance in clinical practice and patient outcomes based upon application of new and reviewed information derived from the educational program in their clinical practice, as well as for successful recertification and continued maintenance. Attendees will be provided information regarding the new ABPN MOC requirements, including CME credits, self-assessment activities, and Improvement in Medical Practice (PIP) clinical and feedback modules.
Recommended Audience: Practitioners, General Neurologist, Academicians, Specialist Neurologist, Neurohospitalist
Core Competencies: Patient Care, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Timeline

Sunday, January 14

8:00 a.m.-8:15 a.m.  
Introduction
Ralph F. Józefowicz, MD, FAAN, Rochester, NY 

8:15 a.m. - 9:15 a.m.  
Vascular Disorders
Eugene L. Scharf, MD, Rochester, MN

9:15 a.m.-10:15 a.m.
 
Demyelinating Disorders
Nicholas Elwood Johnson, MD, Salt Lake City, UT

10:15 a.m.-10:30 a.m.  
Break

10:30 a.m.-11:30 a.m.
Developmental and Congenital Disorders
Erika Levy Wexler, MD, Minneapolis, MN

11:30 a.m.-12:30 p.m.  
Epilepsy
Jonathan K. Smith, MD, Bethesda, MD

12:30 p.m.-1:30 p.m.  
Lunch

1:30 p.m.-2:30 p.m.
Brain and Spine Trauma
Eugene L. Scharf, MD, Rochester, MN
 
2:30 p.m.-2:45 p.m.  
Break

2:45 p.m.-3:45 p.m.  
Headache and Pain
Christopher Tarolli, MD, Rochester, NY

3:45 p.m.-5:00 p.m.

Neuromuscular Disorders
Nicholas Elwood Johnson, MD, Salt Lake City, UT

Monday, January 15

8:00 a.m.-9:00 a.m.
Movement Disorders
Christopher Tarolli, MD, Rochester, NY

9:00 a.m.-10:00 a.m.  
Sleep Disorders
Jonathan K. Smith, MD, Bethesda, MD

10:00 a.m.-10:15 a.m.  
Break

10:15 a.m.-11:15 a.m.  
Infectious Diseases
Erika Levy Wexler, MD, Minneapolis, MN

11:15 a.m.-12:00 p.m.  
ABPN MOC Program
Ralph F. Józefowicz, MD, FAAN, Rochester, NY

Related Content

MEMBER LOG IN

Forgot password?

Advertisement
Advertisement